BlogFaslodex (Fulvestrant) 250 mg – Hormonal Therapy for Breast Cancer Faslodex (Fulvestrant)
Faslodex (Fulvestrant) 250 mg – Hormonal Therapy for Breast Cancer Faslodex (Fulvestrant)
Faslodex (Fulvestrant) is a hormonal therapy used in the treatment of HR-positive breast cancer, particularly in advanced or metastatic cases. It helps slow the growth of cancer cells that depend on estrogen.
What is Faslodex (Fulvestrant)?
Faslodex belongs to a class of drugs known as Estrogen Receptor Antagonists.
Some types of breast cancer rely on estrogen to grow and spread. Faslodex works by:
Blocking estrogen receptors in cancer cells
Reducing the effect of estrogen on tumors
Slowing cancer growth and progression
In simple terms: It prevents cancer cells from using estrogen to grow.
Indications
Faslodex (Fulvestrant) is used in:
HR-positive breast cancer
Advanced or metastatic disease
Cases previously treated with hormonal therapy
Combination therapy with targeted agents such as CDK4/6 inhibitors
Dosage and Administration
Standard dose: 250 mg or according to treatment protocol
Administered as an intramuscular injection
Injection schedule is determined by the physician
May be used alone or in combination with other therapies
Common Side Effects
May include:
Injection site pain
Hot flashes
Nausea
Fatigue
Joint or muscle pain
Headache
These side effects are usually manageable with proper monitoring.
Monitoring During Treatment
Patients on Faslodex (Fulvestrant) require:
Assessment of tumor response
Symptom evaluation
Liver function monitoring when needed
Regular imaging and follow-up examinations
Availability & How to Access Treatment
Faslodex (Fulvestrant) is available through Macrocare’s approved partners.
You can now request and access the medication easily through us.
WhatsApp contact for medication requests: Click here
Faslodex (Fulvestrant)Faslodex (Fulvestrant) 250 mg is an effective hormonal therapy that helps slow the progression of HR-positive breast cancer by blocking estrogen activity in cancer cells.
Medical Disclaimer: This content is for educational purposes only and does not replace professional medical advice. Treatment decisions should always be made by a qualified physician.